Overview

Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)

Status:
Withdrawn
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This study will look at if a low-dose regimen of acitretin is helpful in treating a skin rash caused by the chemotherapy drug, erlotinib.
Phase:
Phase 4
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
OSI Pharmaceuticals
Treatments:
Acitretin
Erlotinib Hydrochloride